Atlassian (NASDAQ:TEAM) Director Sells $1,246,788.90 in Stock

Atlassian Corporation PLC (NASDAQ:TEAM) Director Scott Farquhar sold 7,665 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $162.66, for a total transaction of $1,246,788.90. Following the completion of the sale, the director owned 283,605 shares in the company, valued at $46,131,189.30. This represents a 2.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Scott Farquhar also recently made the following trade(s):

• On Monday, November 3rd, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $172.79, for a total transaction of $1,324,435.35.
• On Friday, October 31st, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $167.61, for a total transaction of $1,284,730.65.
• On Wednesday, October 29th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $160.41, for a total transaction of $1,229,542.65.
• On Monday, October 27th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $165.03, for a total transaction of $1,264,954.95.
• On Friday, October 24th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $164.50, for a total value of $1,260,892.50.
• On Wednesday, October 22nd, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $169.16, for a total value of $1,296,611.40.
• On Friday, October 17th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $151.21, for a total value of $1,159,024.65.
• On Monday, October 20th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $157.28, for a total value of $1,205,551.20.
• On Wednesday, October 15th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $151.83, for a total value of $1,163,776.95.
• On Monday, October 13th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.81, for a total transaction of $1,132,963.65.

Atlassian Price Performance

NASDAQ:TEAM opened at $157.83 on Friday. Atlassian Corporation PLC has a 12-month low of $144.32 and a 12-month high of $326.00. The firm has a market cap of $41.40 billion, a price-to-earnings ratio of -222.29, a price-to-earnings-growth ratio of 37.43 and a beta of 0.95. The company’s 50-day moving average is $163.23 and its two-hundred day moving average is $186.56. The company has a current ratio of 1.26, a quick ratio of 1.22 and a debt-to-equity ratio of 0.72.

Atlassian (NASDAQ:TEAM) last posted its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.21. Atlassian had a negative net margin of 3.38% and a negative return on equity of 7.11%. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the previous year, the business posted $0.77 earnings per share. The company’s revenue was up 20.6% on a year-over-year basis. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts expect that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Institutional Trading of Atlassian

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Capco Asset Management LLC acquired a new position in Atlassian during the second quarter valued at approximately $25,000. Physician Wealth Advisors Inc. raised its stake in shares of Atlassian by 60.4% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after acquiring an additional 61 shares during the period. Smithfield Trust Co lifted its holdings in shares of Atlassian by 90.7% during the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock valued at $34,000 after acquiring an additional 78 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after acquiring an additional 161 shares in the last quarter. Finally, Atlantic Union Bankshares Corp boosted its position in Atlassian by 19,900.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock worth $32,000 after purchasing an additional 199 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Barclays decreased their price objective on Atlassian from $244.00 to $215.00 and set an “overweight” rating on the stock in a report on Friday, August 8th. BMO Capital Markets raised their price target on Atlassian from $190.00 to $195.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Oppenheimer dropped their price objective on shares of Atlassian from $300.00 to $275.00 and set an “outperform” rating for the company in a research note on Monday, July 21st. Wells Fargo & Company started coverage on shares of Atlassian in a report on Tuesday, September 30th. They set an “overweight” rating and a $216.00 price objective on the stock. Finally, Piper Sandler restated an “overweight” rating and issued a $300.00 target price on shares of Atlassian in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $239.44.

About Atlassian

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.